Search

Your search keyword '"Chataway J"' showing total 15 results

Search Constraints

Start Over You searched for: Author "Chataway J" Remove constraint Author: "Chataway J" Topic business.industry Remove constraint Topic: business.industry
15 results on '"Chataway J"'

Search Results

1. Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART).:a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis

2. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

3. Interferon β-1b-neutralizing antibodies 5 years after clinically isolated syndrome

4. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial

5. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

6. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study

7. Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality

8. Study protocol: improving cognition in people with progressive multiple sclerosis: a multi-arm, randomized, blinded, sham-controlled trial of cognitive rehabilitation and aerobic exercise (COGEx)

9. The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience

10. Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy

11. Facing the urgency of therapies for progressive MS — a Progressive MS Alliance proposal

12. Cardiorespiratory fitness and free-living physical activity are not associated with cognition in persons with progressive multiple sclerosis: Baseline analyses from the CogEx study

13. Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin

14. Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England

15. Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting

Catalog

Books, media, physical & digital resources